======= C15orf38 =======
== Gene Information ==
* **Official Symbol**: ARPIN
* **Official Name**: actin related protein 2/3 complex inhibitor
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=348110|348110]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q7Z6K5|Q7Z6K5]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=C15orf38&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20C15orf38|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/615543|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Regulates actin polymerization by inhibiting the actin- nucleating activity of the Arp2/3 complex; the function is competetive with nucleation promoting factors. Participates in an incoherent feedforward loop at the lamellipodium tip where it inhibits the ARP2/2 complex in response to Rac signaling and where Rac also stimulates actin polymerization through the WAVE complex. Involved in steering cell migration by controlling its directional persistence. {ECO:0000269|PubMed:24132237}.
|UPF0552|
|negative regulation of lamellipodium morphogenesis|
|directional locomotion|
|negative regulation of lamellipodium organization|
|negative regulation of actin nucleation|
|regulation of lamellipodium morphogenesis|
|regulation of actin nucleation|
|regulation of lamellipodium organization|
|negative regulation of supramolecular fiber organization|
|negative regulation of cytoskeleton organization|
|regulation of actin filament polymerization|
|lamellipodium|
|negative regulation of cell projection organization|
|regulation of actin polymerization or depolymerization|
|regulation of actin filament length|
|regulation of protein polymerization|
|negative regulation of cell migration|
|regulation of actin filament organization|
|negative regulation of cell motility|
|negative regulation of cellular component movement|
|negative regulation of locomotion|
|regulation of actin cytoskeleton organization|
|regulation of supramolecular fiber organization|
|negative regulation of organelle organization|
|regulation of cellular component size|
|regulation of actin filament-based process|
|regulation of protein complex assembly|
|regulation of cell morphogenesis|
|regulation of anatomical structure size|
|regulation of cytoskeleton organization|
|regulation of plasma membrane bounded cell projection organization|
|negative regulation of cellular component organization|
|regulation of cell projection organization|
|regulation of cell migration|
|regulation of cell motility|
|negative regulation of developmental process|
|regulation of cellular component biogenesis|
|regulation of locomotion|
|regulation of cellular component movement|
|regulation of anatomical structure morphogenesis|
|regulation of organelle organization|
|locomotion|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp416|Tubacin 1.6μM R07 exp416]]|-1.7|
|[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|1.97|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 12434
* **Expression level (log2 read counts)**: 3.53
{{:chemogenomics:nalm6 dist.png?nolink |}}